Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations (Q38624850)

4 September 2017

Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations (English)

1 reference

chronic obstructive pulmonary disease

4 September 2017

0 references

1 reference

Xavier Pomares

1

1 reference

4 September 2017

Concepción Montón

2

1 reference

4 September 2017

Mateu Espasa

3

1 reference

4 September 2017

Jordi Casabon

4

1 reference

4 September 2017

Eduard Monsó

5

1 reference

4 September 2017

Miguel Gallego

6

1 reference

4 September 2017

language of work or name

English

0 references

publication date

6 September 2011

1 reference

International Journal of Chronic Obstructive Pulmonary Disease

4 September 2017

1 reference

4 September 2017

6

1 reference

4 September 2017

449-456

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

4 September 2017

start time

1 September 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186743

Role of macrolide therapy in chronic obstructive pulmonary disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186743

Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186743

Suppression of Pseudomonas aeruginosa quorum-sensing systems by macrolides: a promising strategy or an oriental mystery?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186743

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186743

Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186743

Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186743

Azithromycin for cystic fibrosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186743

Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186743

Macrolide antibiotics for cystic fibrosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186743

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186743

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186743

Toward a consensus definition for COPD exacerbations

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186743

Chronic sputum production: correlations between clinical features and findings on high resolution computed tomographic scanning of the chest

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186743

Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186743

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186743

[Macrolides and ketolides].

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186743

Azithromycin-induced torsade de pointes

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186743

Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186743

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186743

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186743

Erythromycin and common cold in COPD

3 December 2018

1 reference

12 December 2020

Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush

1 reference

12 December 2020

Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin

1 reference

12 December 2020

Relationship Between Bacterial Flora in Sputum and Functional Impairment in Patients With Acute Exacerbations of COPD

1 reference

12 December 2020

[Diagnosis and treatment of bronchiectasis. Spanish Society of Pneumology and Thoracic Surgery]

1 reference

12 December 2020

Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations

1 reference

12 December 2020

Antibiotic prophylaxis for chronic obstructive pulmonary disease: resurrecting an old idea

1 reference

12 December 2020

[Causes of death and risk factors for mortality in patients with severe chronic obstructive pulmonary disease]

1 reference

12 December 2020

Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study

1 reference

12 December 2020

[Respiratory day hospital: what have we learned?]

1 reference

12 December 2020

Identifiers

DOI

10.2147/COPD.S23655

1 reference

4 September 2017

1 reference

4 September 2017

PubMed publication ID

22003290

1 reference